V

Vapotherm Inc
OTC:VAPO

Watchlist Manager
Vapotherm Inc
OTC:VAPO
Watchlist
Price: 1.27 USD
Market Cap: $13.5m

Net Margin

-99.6%
Current
Improving
by 41.1%
vs 3-y average of -140.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-99.6%
=
Net Income
$-58.2m
/
Revenue
$68.7m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-99.6%
=
Net Income
$-58.2m
/
Revenue
$68.7m

Peer Comparison

Country Company Market Cap Net
Margin
US
Vapotherm Inc
F:VA21
137.6m EUR
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
185.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.5B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.8B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.7B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.7B USD
Loading...

Market Distribution

Lower than 84% of companies in the United States of America
Percentile
16th
Based on 15 072 companies
16th percentile
-84.7%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Vapotherm Inc
Glance View

Market Cap
13.5m USD
Industry
Health Care

Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. The company is headquartered in Exeter, New Hampshire and currently employs 510 full-time employees. The company went IPO on 2018-11-14. The firm is focused on the care of patients of all ages suffering from the respiratory distress often associated with complex lung diseases, such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), pneumonia, asthma and COVID-19. Its device solutions are focused on high velocity nasal insufflation (HVNI), which delivers non-invasive ventilatory support to patients suffering from respiratory distress. Its HVNI technology delivers heated, humidified and oxygenated air at a high velocity through a small-bore nasal interface. The company offers four versions of its Precision Flow systems, which includes Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. Its digital solutions are focused on at home patient monitoring. The firm also provides various clinical solutions.

VAPO Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-99.6%
=
Net Income
$-58.2m
/
Revenue
$68.7m
What is Vapotherm Inc's current Net Margin?

The current Net Margin for Vapotherm Inc is -99.6%, which is above its 3-year median of -140.8%.

How has Net Margin changed over time?

Over the last 3 years, Vapotherm Inc’s Net Margin has decreased from -50.1% to -99.6%. During this period, it reached a low of -186.8% on Mar 31, 2023 and a high of -40.6% on Mar 31, 2021.

Back to Top